...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >COMPARATIVE MUCOPENETRATION ABILITY OF METRONIDAZOLE LOADED CHITOSAN AND PEGYLATED CHITOSAN NANOPARTICLES
【24h】

COMPARATIVE MUCOPENETRATION ABILITY OF METRONIDAZOLE LOADED CHITOSAN AND PEGYLATED CHITOSAN NANOPARTICLES

机译:甲硝唑负载的壳聚糖和聚乙二醇化壳聚糖纳米粒子的比较互穿能力

获取原文

摘要

Objective: The objective of this study is to compare the mucopenetration ability of metronidazole loaded chitosan (CS) and pegylated CS nanoparticles. Methods: Nanoparticles were prepared by ionic gelation technique using negatively charged pH sensitive polymer, hydroxyl propyl methyl cellulose phthalate with positively charged CS and methoxy polyethylene glycol-grafted-CS (mPEG-g-CS). mPEG-g-CS was synthesized by formaldehyde linkage method and characterized by Fourier transform infrared spectroscopy. The optimized formulations were compared for morphology, particle size, polydispersity index (PDI), entrapment efficiency, bioadhesion detachment force, in vitro and in vivo mucopenetration for CS-mPEG-g-CS nanoparticles. Results: The morphological assessment revealed smooth spherical particles with uniform dispersions. The optimized formulations particle size was found to be 202.7±27 nm and 294.1±46 nm, zeta potential 26.94±2.4 mV and 6.0±1.3 mV. PDI 0.231 and 0.268, entrapment efficiency 79.8±5.4% and 83.6±9.7%, bio-adhesion detachment force 14.98*103 dyne/cm2 and 10.67*103 dynes/cm2, in vitro mucopenetration 78% and 98% for CS-mPEG-g-CS, respectively. The qualitative in vivo mucopenetration result confirms retention of fluorescein isothiocyanate (FITC) labeled mPEG-g-CS nanoparticles till 24 hrs. Conclusion: Nanoparticles with lesser zeta potential and mucoadhesion showed higher mucosal penetration which is evident from FITC labeled histopathological mucus penetration test. Studies thus provided evidence that planned pharmaceutical strategies open new vistas for effective treatment of mucosal infections.
机译:目的:本研究的目的是比较甲硝唑负载的壳聚糖(CS)和聚乙二醇化的CS纳米颗粒的粘膜渗透能力。方法:采用带负电的pH敏感聚合物,带正电的CS的邻苯二甲酸羟丙基甲基纤维素邻苯二甲酸酯和甲氧基聚乙二醇接枝的CS(mPEG-g-CS),通过离子凝胶技术制备纳米粒子。通过甲醛键合法合成了mPEG-g-CS,并通过傅里叶变换红外光谱对其进行了表征。比较了优化制剂的CS-mPEG-g-CS纳米颗粒的形态,粒径,多分散指数(PDI),包封率,生物粘附剥离力,体外和体内粘膜渗透。结果:形态学评估显示光滑的球形颗粒具有均匀的分散。发现优化的制剂粒径为202.7±27nm和294.1±46nm,ζ电势为26.94±2.4mV和6.0±1.3mV。 PDI 0.231和0.268,包封率79.8±5.4%和83.6±9.7%,生物粘附剥离力14.98 * 103达因/平方厘米和10.67 * 103达因/平方厘米,CS-mPEG-g的体外粘膜渗透率分别为78%和98% -CS,分别。定性的体内粘膜渗透结果证实了荧光素异硫氰酸酯(FITC)标记的mPEG-g-CS纳米颗粒保留了24小时。结论:具有较小的ζ电势和粘膜粘附性的纳米颗粒具有较高的粘膜渗透性,这从FITC标记的组织病理学粘液渗透性试验中可以明显看出。因此,研究提供了证据,表明计划的药物策略为有效治疗粘膜感染开辟了新的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号